Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Efficacy of rTMS in Depression in Individuals With Autism Spectrum Disorder (ASD)

NCT07258914 is registered in ClinicalTrials.gov with Hospital Center Guillaume Régnier as lead sponsor.

NCT NCT07258914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07258914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Efficacy of rTMS in Depression in Individuals With Autism Spectrum Disorder (ASD)
Lead sponsor
Hospital Center Guillaume Régnier
Phase
Not applicable
Overall status
Recruiting
Start date
December 19, 2024
Completion date
February 19, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, depression, major depressive episode (mde)